134 Results for "

oligomerization

" in MedChemExpress (MCE) Product Catalog:
Products (134)

134 Results for "oligomerization" in MCE Product Catalog:

144
144 Publications Verification
Cat. No.: HY-100573
CAS No.: 1360614-48-7
Purity:  99.47%
Necrosulfonamide is a MLKL and Gasdermin D (GSDMD) inhibitor, capable of separately inhibiting necroptosis and pyroptosis of cells. Necrosulfonamide does not affect the activation of upstream signals, but specifically inhibits the downstream executor oligomerization step. Necrosulfonamide reduces the expression of the key kinases NLRP3 and caspase-1 involved in necroptosis and pyroptosis, activate the Nrf2 pathway and the downstream antioxidant enzymes, and also downregulates a variety of inflammatory factors. Necrosulfonamide plays significant roles in various diseases such as neurodegenerative diseases (such as Parkinson’s disease), tissue damage and ischemia-reperfusion injury, inflammatory bowel disease, osteoarthritis and fracture repair, and hair loss by regulating two important programmed necrosis pathways .
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-129122
CAS No.: 2086257-77-2
Purity:  99.46%
Target:  

VDAC

VBIT-4 is an inhibitor of voltage-dependent anion channel 1 (VDAC1) oligomerization with a binding affinity (Kd) of 17 μM. VBIT-4, as an apoptosis inhibitor, can be used for therapeutic purposes in apoptosis-associated disorders, such as neurodegenerative and cardiovascular diseases .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-136555
CAS No.: 1595278-21-9
Purity:  99.93%
Research Areas:  

Inflammation/Immunology

GSK717 is a potent, selective NOD2 (nucleotide-binding oligomerization domain 2) inhibitor. GSK717 inhibits muramyl dipeptide (MDP)-induced NOD2-mediated signaling, with an IC50 of 400 nM for MDP-stimulated IL-8 secretion in HEK293/hNOD2 cells .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-144226
CAS No.: 1787787-60-3
Purity:  98.23%
NLRP3/AIM2-IN-3 (compound 59) is a potent inhibitor with differential species specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis. NLRP3/AIM2-IN-3 shows inhibitory efficacy against pyroptosis in THP-1 macrophages stimulated with LPS/nigericin, with an IC50 of 0.077 ± 0.008 μM. NLRP3/AIM2-IN-3 disturbs the interaction of NLRP3 or AIM2 with the adaptor protein ASC and inhibited ASC oligomerization .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-108937
CAS No.: 4550-72-5
Purity:  99.75%
Target:  

VDAC Apoptosis

NSC 15364 is an inhibitor of VDAC1 oligomerization and apoptosis .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-135885
CAS No.: 2089227-65-4
Purity:  98.87%
Target:  

VDAC

Research Areas:  

Neurological Disease

VBIT-12 is a potent VDAC1 inhibitor. VBIT-12 directly interacts with VDAC1 and prevents VDAC1 oligomerization, and thus inhibits apoptotic action of VDAC1 .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-100691
CAS No.: 132819-92-2
Purity:  99.48%
Research Areas:  

Inflammation/Immunology

NOD-IN-1 is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptors, NOD1 and NOD2, with IC50 of 5.74 μM and 6.45 μM, respectively.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-100432
CAS No.: 877963-94-5
Purity:  ≥98.0%
Target:  

PDI

LOC14 is a potent Protein disulfide isomerase (PDI) inhibitor with EC50 and Kd values of 500 nM and 62 nM, respectively. LOC14 exhibits high stability in mouse liver microsomes and blood plasma, low intrinsic microsome clearance, and low plasma-protein binding . LOC14 inhibits PDIA3 activity, decreases intramolecular disulfide bonds and subsequent oligomerization (maturation) of HA in lung epithelial cells .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-17406
CAS No.: 134308-13-7
Synonyms: Ro 40-7592
Tolcapone (Ro 40-7592) is a selective, potent and orally active COMT inhibitor with an IC50of 773 nM. Tolcapone can inhibits α-syn and Aβ42 oligomerization and fibrillogenesis. Tolcapone can cause oxidative stress and induce cancer cells apoptosis and ROS production. Tolcapone can be used for the researches of cancer and neurological disease, such as Parkinson disease and neuroblastoma .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-156798
CAS No.: 2757333-37-0
Purity:  99.74%
ADS032 is a sulfonylurea compound that is an NLRP1 and NLRP3 inflammasome inhibitor. ADS032 reduces the secretion of inflammatory factors and inhibits the oligomerization of ASC. ADS032 has anti-inflammatory effects in a variety of inflammatory models and can be used in the study of inflammatory diseases .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-120079
CAS No.: 1592908-16-1
Purity:  99.00%
Target:  

Bcl-2 Family Apoptosis

Research Areas:  

Cancer

MSN-125 is a potent Bax and Bak oligomerization inhibitor. MSN-125 prevents mitochondrial outer membrane permeabilization (MOMP) with an IC50 of 4 μM. MSN-125 potently inhibits Bax/Bak-mediated apoptosis in HCT-116, BMK Cells, and primary cortical neurons, protects primary neurons against glutamate excitotoxicity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-124329A
CAS No.: 127634-19-9
Purity:  ≥98.0%
Research Areas:  

Cancer

BS3 Crosslinker disodium is a cell-impermeable NHS ester crosslinker. BS3 Crosslinker disodium "covalently locks" two spatially adjacent proteins on the surface of living cells into a covalent complex, and the dimerization/oligomerization status is determined by observing molecular weight shifts via Western blot. BS3 Crosslinker disodium can crosslink EGFR and c-MET to assist in detecting and evaluating their dimerization status. It can be used in research related to oral cancer and glioblastoma .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-18937
CAS No.: 1354825-58-3
Target:  

RIP kinase

Research Areas:  

Cancer

WEHI-345 is a potent and selective RIPK2 kinase inhibitor with an IC50 of 0.13 μM, which delays RIPK2 ubiquitylation and NF-κB activation on oligomerization domain (NOD) stimulation .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N1431
CAS No.: 4429-63-4
Tabersonine is a selective, orally active NLRP3 inhibitor. Tabersonine directly binds to the NACHT domain of NLRP3, inhibiting its ATPase activity and oligomerization, thereby blocking ASC spot formation and caspase-1 activation, and reducing the release of pro-inflammatory cytokines such as IL-1β. Tabersonine also inhibits K63-linked ubiquitination of TRAF6, blocking NF-κB, PI3K/Akt, and p38 MAPK signaling pathways. Tabersonine can inhibit inflammatory responses, induce apoptosis of liver cancer cells through mitochondrial pathways and death receptor pathways, reduce mitochondrial membrane potential, promote cytochrome c release, and activate caspase proteins. Tabersonine is mainly used in the study of NLRP3-driven inflammatory diseases (such as acute lung injury, sepsis, peritonitis) and tumors such as liver cancer .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N1431A
CAS No.: 29479-00-3
Tabersonine hydrochloride is a selective, orally active NLRP3 inhibitor. Tabersonine hydrochloride directly binds to the NACHT domain of NLRP3, inhibiting its ATPase activity and oligomerization, thereby blocking ASC spot formation and caspase-1 activation, and reducing the release of pro-inflammatory cytokines such as IL-1β. Tabersonine hydrochloride also inhibits K63-linked ubiquitination of TRAF6, blocking NF-κB, PI3K/Akt, and p38 MAPK signaling pathways. Tabersonine hydrochloride can inhibit inflammatory responses, induce apoptosis of liver cancer cells through mitochondrial pathways and death receptor pathways, reduce mitochondrial membrane potential, promote cytochrome c release, and activate caspase proteins. Tabersonine hydrochloride is mainly used in the study of NLRP3-driven inflammatory diseases (such as acute lung injury, sepsis, peritonitis) and tumors such as liver cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-135416
CAS No.: 98072-47-0
Streptolysin O is a cholesterol-targeting, thiol-activated pore-forming toxin. Streptolysin O binds to cholesterol via its C-terminal domain 4, oligomerizes to form arc-shaped or ring-shaped structures, inserts amphipathic helices into the lipid bilayer, and forms transmembrane β-barrel pores, resulting in cell permeabilization. Streptolysin O enables controllable cell membrane permeabilization, fluorescent probe delivery, and exogenous molecule uptake .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0914
CAS No.: 112-38-9
Synonyms: Undecylenic acid
10-Undecenoic acid (Undecylenic acid) is an antifungal agent. 10-Undecenoic acid inhibits oligomerization, scavenges ROS and inhibits μ-calpain activity. 10-Undecenoic acid has neuroprotective effects. 10-Undecenoic acid has anticancer effects on a variety of tumors. 10-Undecenoic acid inhibits C. albicans biofilm formation and MRSA infection. 10-Undecenoic acid inhibits quorum sensing signals of Bacillus subtilis and Pseudomonas aeruginosa .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0914A
CAS No.: 557-08-4
Synonyms: Zinc undecylenate
10-Undecenoic acid zinc salt (Undecylenic acid zinc salt) is an antifungal agent. 10-Undecenoic acid zinc salt inhibits oligomerization, scavenges ROS and inhibits μ-calpain activity. 10-Undecenoic acid zinc salt has neuroprotective effects. 10-Undecenoic acid zinc salt has anticancer effects on a variety of tumors. 10-Undecenoic acid zinc salt inhibits C. albicans biofilm formation and MRSA infection. 10-Undecenoic acid zinc salt inhibits quorum sensing signals of Bacillus subtilis and Pseudomonas aeruginosa .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-118948
CAS No.: 1592908-75-2
Purity:  98.68%
Target:  

Bcl-2 Family

Research Areas:  

Neurological Disease

MSN-50 is a Bax and Bak oligomerization inhibitor. MSN-50 efficiently inhibits liposome permeabilization, prevents genotoxic cell death and promotes neuroprotection .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-150147
CAS No.: 2758364-02-0
Purity:  99.83%
Target:  

RAD51 Apoptosis

Research Areas:  

Cancer

CAM833 is a potent orthosteric inhibitor of the interaction between BRCA2 and RAD51 with a Kd of 366 nM against the ChimRAD51 protein. CAM833 also inhibits RAD51 oligomerization. CAM833 increases the progression of G2/M-arrested cells into apoptosis .
loading...
    loading...